McIlrath & Eck »

Tvardi Therapeutics shares owned by McIlrath & Eck

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by McIlrath & Eck from 13F filings

Historical chart of McIlrath & Eck investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by McIlrath & Eck consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by McIlrath & Eck

Quarter filed Position value Share count Share price at filing
2025-09-30 $779 20 38.95
2025-06-30 $467 20 23.35

More positions owned by McIlrath & Eck

Vanguard Index Fds Rowth Etf (VUG)
Ea Series Trust Trive Total Ret (STXT)
Vanguard Index Fds Alue Etf (VTV)
Dimensional Etf Trust Ntl Core Eqt Mk (DFAI)
American Centy Etf Tr Vantis Us Mid C (AVMC)
Vanguard Index Fds Arge Cap Etf (VV)
Dimensional Etf Trust Hort Duration F (DFSD)
Fidelity Covington Trust Igh Divid Etf (FDVV)
Ea Series Trust Trive Enhanced (BUXX)
Ea Series Trust Trive Emerging (STXE)
Vanguard Index Fds Id Cap Etf (VO)
Capital Grp Fixed Incm Etf T Hort Duration (CGSD)
Vanguard Whitehall Fds M Mk Gov Bd Etf (VWOB)
Invesco Exch Traded Fd Tr Ii &p Intl Momnt (IDMO)
Schwab Strategic Tr Ntl Eqty Etf (SCHF)

View all positions for McIlrath & Eck

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
683 Capital Management
Vestal Point Capital
Geode Capital Management
Invesco
FMR
Parkman Healthcare Partners
State Street Corporation
UBS Group
Farallon Capital Management
Northern Trust
Renaissance Technologies
Boothbay Fund Management

View all funds holding Tvardi Therapeutics